Shringar Rao

735 total citations
20 papers, 385 citations indexed

About

Shringar Rao is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Shringar Rao has authored 20 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 12 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Shringar Rao's work include HIV Research and Treatment (13 papers), RNA Research and Splicing (7 papers) and RNA modifications and cancer (4 papers). Shringar Rao is often cited by papers focused on HIV Research and Treatment (13 papers), RNA Research and Splicing (7 papers) and RNA modifications and cancer (4 papers). Shringar Rao collaborates with scholars based in Netherlands, Canada and United States. Shringar Rao's co-authors include Andrew J. Mouland, Raquel Amorim, Meijuan Niu, Tokameh Mahmoudi, Anne Monette, Robert J. Gorelick, Tanvir Hossain, Alessandro Cinti, Andreas E. Kulozik and Kishanda Vyboh and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shringar Rao

20 papers receiving 378 citations

Peers

Countries citing papers authored by Shringar Rao

Since Specialization

Citations

This map shows the geographic impact of Shringar Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shringar Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shringar Rao more than expected).

Fields of papers citing papers by Shringar Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shringar Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shringar Rao. The network helps show where Shringar Rao may publish in the future.

Co-authorship network of co-authors of Shringar Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Shringar Rao. A scholar is included among the top collaborators of Shringar Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shringar Rao. Shringar Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11 2025 ·Frontiers in Immunology ·Ling Li, Manzhi Zhao, Marjan van Meurs, (unknown), (unknown), (unknown), (unknown), Harmen J.G. van de Werken, Shringar Rao, Casper Rokx, Yvonne M. Mueller, Peter D. Katsikis	1
2	PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency 2024 ·iScience ·(unknown), (unknown), (unknown), (unknown), Chengcheng Li, (unknown), (unknown), (unknown), Tsung Wai Kan, (unknown), Dick H. W. Dekkers, Jeroen Demmers, Robert‐Jan Palstra, Shringar Rao, Tokameh Mahmoudi	2
3	Specific quantification of inducible HIV-1 reservoir by RT-LAMP 2024 ·SHILAP Revista de lepidopterología ·Tanvir Hossain, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tsung Wai Kan, Kavidha Reddy, Shringar Rao, Robert‐Jan Palstra, (unknown), Thumbi Ndung’u, Tokameh Mahmoudi	5
4	A 3D organoid platform that supports liver-stage P.falciparum infection can be used to identify intrahepatic antimalarial drugs 2024 ·Heliyon ·Shringar Rao, (unknown), (unknown), Johan A. Slotman, (unknown), Tokameh Mahmoudi	1
5	Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents 2022 ·Nucleic Acids Research ·(unknown), (unknown), Ray Izquierdo-Lara, Shringar Rao, (unknown), (unknown), (unknown), Tsung Wai Kan, David van de Vijver, Dick H. W. Dekkers, Casper Rokx, Panagiotis Moulos, Pantelis Hatzis, Robert‐Jan Palstra, Jeroen Demmers, Tokameh Mahmoudi	8
6	HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Shringar Rao, Tokameh Mahmoudi	10
7	DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism 2022 ·Frontiers in Cell and Developmental Biology ·Shringar Rao, Tokameh Mahmoudi	4
8	Sex differences in HIV-1 persistence and the implications for a cure 2022 ·SHILAP Revista de lepidopterología ·Shringar Rao	5
9	Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models 2021 ·Cell Death and Disease ·Michelle P. Clark, (unknown), Shringar Rao, Liana Mackiewicz, Hugh S. Mason, (unknown), Michael D. Stutz, Sang Hoon Ahn, Linda Earnest, Vitina Sozzi, Margaret Littlejohn, (unknown), Norbert Wiedemann, Elizabeth Vincan, Joseph Torresi, Hans Netter, Tokameh Mahmoudi, Peter Revill, Marc Pellegrini, Gregor Ebert	8
10	3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis 2021 ·Cancer Letters ·Shringar Rao, Tanvir Hossain, Tokameh Mahmoudi	28
11	Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir 2021 ·Nature Communications ·Shringar Rao, (unknown), (unknown), (unknown), (unknown), Robert‐Jan Palstra, Henrieke Prins, Wilfred F. J. van IJcken, Yvonne M. Mueller, Jeroen J. A. van Kampen, Annelies Verbon, Peter D. Katsikis, Charles A. Boucher, Casper Rokx, Rob A. Gruters, Tokameh Mahmoudi	37
12	Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking 2020 ·Cell Reports ·Anne Monette, Meijuan Niu, (unknown), Shringar Rao, Robert J. Gorelick, Andrew J. Mouland	70
13	Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA 2020 ·Viruses ·(unknown), Francesco A. Procopio, Ronald J. Overmars, (unknown), Jolanda J.C. Voermans, Shringar Rao, Henrieke Prins, Casper Rokx, Giuseppe Pantaleo, David van de Vijver, Tokameh Mahmoudi, Charles A. Boucher, Rob A. Gruters, Jeroen J. A. van Kampen	6
14	Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages 2019 ·Retrovirology ·Shringar Rao, Raquel Amorim, Meijuan Niu, (unknown), Michel J. Tremblay, Andrew J. Mouland	21
15	HIV-1 requires Staufen1 to dissociate stress granules and to produce infectious viral particles 2019 ·RNA ·Shringar Rao, (unknown), Anne Monette, Raquel Amorim, Luc DesGroseillers, Andrew J. Mouland	25
16	The RNA surveillance proteins UPF1, UPF2 and SMG6 affect HIV-1 reactivation at a post-transcriptional level 2018 ·Retrovirology ·Shringar Rao, Raquel Amorim, Meijuan Niu, (unknown), Andrew J. Mouland	26
17	HIV-1 NC-induced stress granule assembly and translation arrest are inhibited by the dsRNA binding protein Staufen1 2017 ·RNA ·Shringar Rao, Alessandro Cinti, (unknown), Raquel Amorim, Ji Chang You, Andrew J. Mouland	24
18	Ebola virus VP35 blocks stress granule assembly 2016 ·Virology ·Valerie Le Sage, Alessandro Cinti, (unknown), Raquel Amorim, Shringar Rao, (unknown), Enzo Tramontano, Donald R. Branch, Andrew J. Mouland	49
19	HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA 2015 ·Biomolecules ·Lara Ajamian, (unknown), Shringar Rao, Kishanda Vyboh, Francisco García-de-Gracia, Ricardo Soto‐Rifo, Andreas E. Kulozik, Niels H. Gehring, Andrew J. Mouland	44
20	Electroporation of Adult Zebrafish 2008 ·Methods in molecular biology ·Nalam Madhusudhana Rao, (unknown), Shringar Rao	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact